AKER

Akers Biosciences (AKER)

Akers Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AKER

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/21	06 : 01	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/06/10	05 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/04/12	21 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/04/06	05 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AKER	Akers Biosciences Inc
2023/04/06	05 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/04/01	06 : 03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/03/23	06 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/03/20	22 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/03/14	05 : 30	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AKER	Akers Biosciences Inc
2023/03/08	22 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/03/04	07 : 11	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:AKER	Akers Biosciences Inc
2023/03/02	22 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/03/01	06 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/02/24	05 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/02/23	23 : 01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AKER	Akers Biosciences Inc
2023/02/21	23 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2023/02/14	21 : 41	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AKER	Akers Biosciences Inc
2023/02/04	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/12/15	07 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/12/09	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/11/19	06 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AKER	Akers Biosciences Inc
2022/11/11	07 : 03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AKER	Akers Biosciences Inc